Close Menu

NEW YORK (GenomeWeb) – Canopy Biosciences announced today that it has acquired German cytometry startup Zellkraftwerk as part of its plans to build a wider product and service offering.

According to Canopy, the acquisition creates a "unique multi-omics" company that offers "a powerful union of genomic expertise with cutting-edge cell and tissue analysis solutions" to further help "drug development research and biomarker discovery."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.